Avalo Therapeutics, Inc. (AVTX)
16.11
-1.07
(-6.23%)
USD |
NASDAQ |
Sep 11, 16:00
16.11
0.00 (0.00%)
After-Hours: 17:09
Avalo Therapeutics Gross Profit (TTM) : -0.05M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.05M |
| March 31, 2026 | -0.167M |
| December 31, 2025 | -0.285M |
| September 30, 2025 | -0.223M |
| June 30, 2025 | 0.765M |
| March 31, 2025 | 0.556M |
| December 31, 2024 | 0.737M |
| September 30, 2024 | 0.632M |
| June 30, 2024 | -0.308M |
| March 31, 2024 | -0.03M |
| December 31, 2023 | -0.152M |
| September 30, 2023 | 0.124M |
| June 30, 2023 | 14.56M |
| March 31, 2023 | 14.09M |
| December 31, 2022 | 14.58M |
| September 30, 2022 | 13.83M |
| June 30, 2022 | -0.577M |
| March 31, 2022 | 2.801M |
| December 31, 2021 | 2.358M |
| September 30, 2021 | 3.743M |
| June 30, 2021 | 4.360M |
| March 31, 2021 | 2.373M |
| December 31, 2020 | 4.657M |
| September 30, 2020 | 4.75M |
| Date | Value |
|---|---|
| June 30, 2020 | 5.903M |
| March 31, 2020 | 5.772M |
| September 30, 2019 | 5.202M |
| June 30, 2019 | 4.094M |
| March 31, 2019 | 4.440M |
| December 31, 2018 | 6.310M |
| September 30, 2018 | 5.813M |
| June 30, 2018 | 5.915M |
| March 31, 2018 | 3.786M |
| December 31, 2017 | 1.190M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.0068M |
| September 30, 2016 | -0.0129M |
| June 30, 2016 | -0.0193M |
| March 31, 2016 | -0.0248M |
| December 31, 2015 | -0.0235M |
| September 30, 2015 | -0.0242M |
| June 30, 2015 | -0.0247M |
| March 31, 2015 | -0.0192M |
| June 30, 2014 | -0.0137M |
| March 31, 2014 | -0.0068M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Incyte Corp. | 5.320B |
| AbbVie, Inc. | 45.98B |
| Rezolute, Inc. | -0.031M |
| Alnylam Pharmaceuticals, Inc. | 3.827B |